Table 2.
Relationships of Mission Duration with Aging Biomarkers and Leukocyte Proportions
| Difference in DNA Methylation Marker (95% CI) Aging Biomarker Modela | pb | |
|---|---|---|
| DNAmGrimAge (Years) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | −0.52 (−2.72 to 1.67) | 0.65 |
| 168 days | −4.50 (−6.79 to 2.20) | 0.001 |
| 300 days | −2.12 (−4.41 to 0.17) | 0.09 |
| 512 days | 0.38 (−2.35 to 3.10) | 0.79 |
| Post-mission (527 days) | 0.06 (−2.35 to 2.47) | 0.96 |
| DNAmPhenoAge (Years) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | −2.39 (−5.38 to 0.61) | 0.11 |
| 168 days | −5.90 (−9.03 to −2.77) | 0.001 |
| 300 days | −4.14 (−7.27 to −1.02) | 0.01 |
| 512 days | −3.04 (−6.76 to 0.68) | 0.10 |
| Post-mission (527 days) | −5.41 (−8.70 to −2.12) | 0.003 |
| DNAmTL (kb) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | 0.03 (−0.07 to 0.14) | 0.48 |
| 168 days | 0.02 (−0.08 to 0.12) | 0.67 |
| 300 days | 0.02 (−0.09 to 0.13) | 0.70 |
| 512 days | 0.03 (−0.08 to 0.14) | 0.58 |
| Post-mission (527 days) | −0.01 (−0.11 to 0.08) | 0.76 |
| Pace of Aging (PoA) (Years) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | 0.03 (−0.02 to 0.09) | 0.19 |
| 168 days | 0.01 (−0.04 to 0.07) | 0.60 |
| 300 days | −0.01 (−0.07 to 0.05) | 0.65 |
| 512 days | 0.04 (−0.02 to 0.10) | 0.15 |
| Post-mission (527 days) | 0.002 (−0.05 to 0.05) | 0.94 |
| Mitotic Age (epiTOC2) (Divisions per Stem Cell per Year) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | −397.21 (−710.69 to −83.73) | 0.02 |
| 168 days | −481.53 (−806.91 to −156.16) | 0.006 |
| 300 days | −137.62 (−463.80 to 188.56) | 0.39 |
| 512 days | −313.55 (−698.51 to 71.40) | 0.10 |
| Post-mission (527 days) | −216.67 (−557.20 to 123.87) | 0.20 |
| DNAmGrimAge Component Modela | ||
| DNAm ADM (pg/mL) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | −9.21 (−18.72 to 0.31) | 0.07 |
| 168 days | −22.66 (−32.60 to −12.72) | 0.0003 |
| 300 days | −12.02 (−21.95 to −2.08) | 0.03 |
| 512 days | −0.62 (−12.44 to 11.19) | 0.92 |
| Post-mission (527 days) | −2.53 (−12.99 to 7.93) | 0.64 |
| DNAm B2M (pg/mL) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | −11,537.7 (−54,851.00 to 31,775.68) | 0.58 |
| 168 days | −46,459.3 (−90,099.30 to −28,19.31) | 0.04 |
| 300 days | −42,559.8 (−87,307.27 to 2,187.72) | 0.06 |
| 512 days | 17,348.3 (−31,813.55 to 66,510.23) | 0.47 |
| Post-mission (527 days) | 21,684.3 (21,852.57 to 65,221.21) | 0.31 |
| DNAm Cystatin C (pg/mL) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | 8,025.9 (−11,508.78 to 27,560.51) | 0.40 |
| 168 days | −4,456.8 (−24,120.16 to 15,206.56) | 0.64 |
| 300 days | −5,041.1 (−25,701.20 to 15,619.04) | 0.61 |
| 512 days | −5,248.7 (−26,859.24 to 16,361.76) | 0.62 |
| Post-mission (527 days) | 7,124.1 (−12,024.12 to 26,272.35) | 0.44 |
| DNAm GDF-15 (pg/mL) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | −36.51 (−103.14 to 30.12) | 0.26 |
| 168 days | −96.62 (−164.04 to −29.20) | 0.008 |
| 300 days | −39.12 (−111.96 to 33.71) | 0.27 |
| 512 days | 10.92 (−61.50 to 83.35) | 0.76 |
| Post-mission (527 days) | −19.67 (−83.85 to 44.51) | 0.53 |
| DNAm Leptin (pg/mL) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | 1,225.78 (−57.88 to 2,509.45) | 0.06 |
| 168 days | −168.65 (−1,463.03 to 1,125.73) | 0.79 |
| 300 days | 188.22 (−1,135.56 to 1,512.00) | 0.77 |
| 512 days | −306.50 (−1,769.60 to 1,156.60) | 0.67 |
| Post-mission (527 days) | 360.37 (−935.18 to 1,655.92) | 0.57 |
| DNAm Packyears (Pack-Years) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | 0.36 (−3.11 to 3.84) | 0.83 |
| 168 days | 0.14 (−3.40 to 3.67) | 0.94 |
| 300 days | 0.70 (−2.87 to 4.28) | 0.68 |
| 512 days | 1.21 (−2.87 to 5.29) | 0.54 |
| Post-mission (527 days) | 0.77 (−2.84 to 4.38) | 0.66 |
| DNAm PAI-1 (pg/mL) | ||
| Baseline (−7 days) | reference | ND |
| 60 days | 1,160.27 (−383.77 to 2,704.31) | 0.13 |
| 168 days | −1,364.61 (−2,920.97 to 191.75) | 0.08 |
| 300 days | 261.24 (−1,390.39 to 1,912.88) | 0.74 |
| 512 days | −218.50 (−1,914.57 to 1,477.58) | 0.79 |
| Post-mission (527 days) | −132.06 (−1,635.02 to 1,370.91) | 0.86 |
| DNAm TIMP-1 (pg/mL) | ||
| Baseline (−7 days) | Reference | ND |
| 60 days | −170.00 (−683.06 to 343.07) | 0.50 |
| 168 days | −681.05 (−1,198.05 to−164.04) | 0.01 |
| 300 days | −280.04 (−809.90 to 249.82) | 0.28 |
| 512 days | 71.26 (−511.54 to 654.06) | 0.80 |
| Post-mission (527 days) | 57.91 (−458.20 to 574.01) | 0.82 |
| Leukocyte Modelc | ||
| B Cells | ||
| Baseline (−7 days) | reference | ND |
| 60 days | −0.003 (−0.02 to 0.01) | 0.65 |
| 168 days | −0.00005 (−0.02 to 0.01) | 0.99 |
| 300 days | 0.02 (0.001 to 0.03) | 0.03 |
| 512 days | 0.02 (0.002 to 0.03) | 0.03 |
| Post-mission (527 days) | −0.003 (−0.02 to 0.01) | 0.73 |
| CD4 Naive Cells | ||
| Baseline (−7 days) | reference | |
| 60 days | −53.30 (−111.04 to 4.44) | 0.07 |
| 168 days | −84.27 (−142.01 to −26.54) | 0.01 |
| 300 days | −11.06 (−68.80 to 46.67) | 0.70 |
| 512 days | 41.34 (−16.39 to 99.08) | 0.15 |
| Post-mission (527 days) | −36.39 (−94.12 to 21.35) | 0.21 |
| CD4 T Cells | ||
| Baseline (−7 days) | reference | ND |
| 60 days | 0.01 (−0.02 to 0.04) | 0.54 |
| 168 days | 0.001 (−0.03 to 0.03) | 0.96 |
| 300 days | 0.06 (0.03 to 0.09) | 0.0008 |
| 512 days | 0.05 (0.02 to 0.09) | 0.003 |
| Post-mission (527 days) | −0.001 (−0.03 to 0.03) | 0.93 |
| CD8 Naive Cells | ||
| Baseline (−7 days) | reference | ND |
| 60 days | −20.67 (−40.00 to −1.36) | 0.04 |
| 168 days | −8.23 (−27.55 to 11.09) | 0.39 |
| 300 days | 1.27 (−18.05 to 20.59) | 0.89 |
| 512 days | 37.95 (18.63 to 57.27) | 0.0004 |
| Post-mission (527 days) | 1.13 (−18.19 to 20.45) | 0.91 |
| CD8pCD28nCD45Ran T Cells | ||
| Baseline (−7 days) | reference | ND |
| 60 days | 1.36 (−1.06 to 3.79) | 0.26 |
| 168 days | 1.76 (−0.67 to 4.18) | 0.15 |
| 300 days | −1.39 (−3.81 to 1.03) | 0.25 |
| 512 days | 0.03 (−2.39 to 2.45) | 0.98 |
| Post-mission (527 days) | 1.76 (−0.66 to 4.18) | 0.15 |
| CD8 T Cells | ||
| Baseline (−7 days) | reference | ND |
| 60 days | −0.01 (−0.04 to 0.01) | 0.31 |
| 168 days | −0.03 (−0.06 to −0.003) | 0.03 |
| 300 days | −0.002 (−0.03 to 0.02) | 0.86 |
| 512 days | 0.02 (−0.007 to 0.05) | 0.14 |
| Post-mission (527 days) | −0.02 (−0.04 to 0.008) | 0.17 |
| Granulocytes | ||
| Baseline (−7 days) | reference | ND |
| 60 days | 0.01 (−0.04 to 0.06) | 0.70 |
| 168 days | 0.04 (−0.008 to 0.09) | 0.10 |
| 300 days | 0.0008 (−0.05 to 0.05) | 0.98 |
| 512 days | −0.05 (−0.10 to 0.002) | 0.06 |
| Post-mission (527 days) | 0.05 (0.0009 to 0.10) | 0.05 |
| Monocytes | ||
| Baseline (−7 days) | reference | ND |
| 60 days | 0.02 (0.002 to 0.03) | 0.03 |
| 168 days | 0.01 (−0.004 to 0.03) | 0.15 |
| 300 days | −0.01 (−0.03 to 0.0002) | 0.05 |
| 512 days | −0.01 (−0.02 to 0.007) | 0.30 |
| Post-mission (527 days) | 0.002 (−0.01 to 0.02) | 0.74 |
| NK Cells | ||
| Baseline (−7 days) | reference | ND |
| 60 days | −0.03 (−0.06 to −0.005) | 0.02 |
| 168 days | −0.02 (−0.04 to 0.01) | 0.29 |
| 300 days | −0.05 (−0.08 to −0.02) | 0.002 |
| 512 days | −0.03 (−0.06 to −0.004) | 0.03 |
| Post-mission (527 days) | −0.04 (−0.07 to −0.007) | 0.02 |
| Plasmablasts | ||
| Baseline (−7 days) | reference | ND |
| 60 days | −0.02 (−0.13 to 0.08) | 0.64 |
| 168 days | 0.03 (−0.07 to 0.14) | 0.53 |
| 300 days | −0.17 (−0.27 to −0.06) | 0.003 |
| 512 days | −0.17 (−0.28 to −0.07) | 0.003 |
| Post-mission (527 days) | −0.02 (−0.12 to 0.09) | 0.71 |
Models adjusted for baseline DNAmAgeSkinBloodClock and white blood cell proportions.
Italicized p values are considered statistically significant in these analyses. ND, no data.
Models adjusted for baseline DNAmAgeSkinBloodClock.